Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury

Toxicology

Volumn 219, Issue 1-3, 2006, Pages 142-149

  Ozdemir, Ramazan ^a   Parlakpinar, Hakan ^a   Polat, Alaadin ^a   Colak, Cemil ^b   Ermis, Necip ^a   Acet, Ahmet ^a  

^a INONU UNIVERSITY   (Turkey)

^b Republic of Turkey Prime Ministry   (Turkey)

Author keywords

Endothelin; ETA receptor antagonist (BQ 123); NO; Rat; Reactive oxygen radicals

Indexed keywords

CATALASE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; GLUTATHIONE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; ENDOTHELIN A RECEPTOR; MALONALDEHYDE; OXIDIZING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG INHIBITION; ENDOTHELIAL DYSFUNCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART RATE; HEMODYNAMIC PARAMETERS; LEFT CORONARY ARTERY; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TERATOGENICITY; ANIMAL; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; HEART INFARCTION; HEART MUSCLE; HEMODYNAMICS; METABOLISM; OXIDATIVE STRESS; PATHOLOGY;

ANIMALIA;

ANIMALS; BLOOD PRESSURE; HEART RATE; HEMODYNAMIC PROCESSES; MALE; MALONDIALDEHYDE; MYOCARDIAL INFARCTION; MYOCARDIUM; OXIDANTS; OXIDATIVE STRESS; PEPTIDES, CYCLIC; RATS; RECEPTOR, ENDOTHELIN A; REPERFUSION INJURY;

EID: 31044447786     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2005.11.022     Document Type: Article

References (45)

1. H. Aebi Catalase U. Bergmeyer Methods of Enzymatic Analysis 1974 Academic Press New York 673 677
2. M.A. Aladag, Y. Turkoz, E. Sahna, H. Parlakpinar, and M. Gul The attenuation of vasospasm by using a SOD mimetic after experimental subarachnoidal haemorrhaga in rats Acta. Neurochir. 145 2003 673 677
3. C. Basso, G. Thiene, M. Della Barbera, A. Angelini, M. Kirchengast, and S. Iliceto Endothelin-A receptor antagonist administration immediately after experimental myocardial infarction with reperfusion does not affect scar healing in dogs Cardiovasc. Res. 55 2002 113 121
4. B. Battistini, and P. Dussault The many aspects of endothelins in ischemia-reperfusion injury: emergence of a key mediator J. Invest. Surg. 11 1998 297 313
5. A. Benigni, and G. Remuzzi Endothelin antagonists Lancet 353 1999 133 138
6. A. Beresewicz, E. Czarnowska, and M. Maczewski Ischemic preconditioning and superoxide dismutase protect against endothelial dusfunction and endothelium glycocalyx disruption in the post-ischemic guinea-pig hearts Mol. Cell. Biochem. 186 1998 87 92
7. K. Bhagat Endothelial function and myocardial infarction Cardiovasc. Res. 39 1998 312 317
8. P. Cernacek, D.J. Steward, J.-C. Monge, and J.-C. Rouleau The endothelin system and its role in acute myocardial infarction Can. J. Physiol. Pharmacol. 81 2003 598 606
9. A receptor blockade during peri-infarction period in the rat Can. J. Cardiol. 17 2001 174
10. M. Crino, E. Martin, M. Yano, and I.W. Rodger Cardiovascular and renal actions of the endothelin B receptor in pigs J. Cardiovasc. Pharmacol. 29 1997 704 712
11. A receptor subtype in the anesthized rat: effect of BQ-123 on systemic haemodynamic responses Eur. J. Pharmacol. 221 1992 315 324
12. J.M. Erikson, and C.E. Velasco Endothelin-1 and myocardial preconditioning Am. Heart J. 132 1996 869 876
13. E. Fadillioglu, H.R. Yilmaz, H. Erdogan, and S. Sogut The activities of tissue xanthine oxidase and adenosine deaminase and the levels of hydroxyproline and nitric oxide in rat hearts subjected to doxorubicin: protective effect of erdosteine Toxicology 30 2003 153 158
14. A.T. Ganon, Q.D. Wang, and J. Pernow The endothelin A receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischemia/reperfusion Cardiovasc. Res. 39 1998 674 682
15. A. Garjani, C.L. Wainwright, I.J. Zeitlin, C. Wilson, and S.J. Slee Effects of endothelin-1 and the ET-A receptor antagonist, BQ-123, on ischemic arrhythmias in anesthetized rats J. Cardiovasc. Pharmacol. 25 1995 634 642
16. G.J. Grover, S. Dzwonczyk, and C.S. Parham The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion Cardiovasc. Res. 27 1993 1613 1618
17. P.R. Hansen Myocardial reperfusion injury: experimental evidence and clinical relevance Eur. Heart J. 16 1995 734 740
18. X.U. Hong, L.I.N. Li, and Y. Wen-Jun Antiarrhytmic effect of endothelin-A receptor antagonist on acute ischemic arrhythmia in isolated rat heart Acta Pharmacol. Sin. 24 2003 37 44
19. K. Ishiada, K. Takeshige, and S. Minakami Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenyalanin Biochem. Biophys. Res. Commun. 173 1990 496 500
20. S.M. Karuse, J.J. Lynch, I.I. Stabilito, and R.F. Woltmann Intravenous administration of the endothelin-1 antagonist BQ-123 does not ameliorate myocardial ischaemic injury following acute coronary artery occlusion in the dog Cardiovasc. Res. 28 1994 1672 1678
21. M. Kojima, K. Kusumoto, S. Fujiwara, T. Watanbe, and M. Fujino Role of endogenous endothelin in the extension of myocardial infarct size studied with the endothelin receptor antagonist TAK-044 J. Cardiovasc. Pharmacol. 26 1995 3397 3399
22. B.K. Kramer, K.P. Ittner, M.E. Beyer, H.M. Hoffmeister, and G.A.J. Riegger Circulatory and myocardial effects of endothelin J. Mol. Med. 75 1997 886 890
23. H.C. Lam, K. Takahashi, M.A. Ghatei, A.N. Warrens, A.J. Rees, and S.R. Bloom Immunoreactive endothelin in human plasma, urine, milk, and saliva J. Cardiovasc. Pharmacol. 7 1991 S390 S393
24. D.J. Lefer, R. Scalia, B. Campbell, T. Nossuli, R. Hayward, M. Salamon, J. Grayson, and A.M. Lefer Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats J. Clin. Invest. 99 1997 684 691
25. 125I]ET-1 binding to rat cardiac membranes J. Cardiovasc. Pharmacol. 15 1990 36 43
26. Y.H. Liu, X.P. Yang, V.G. Sharov, D.H. Sigmon, H.N. Sabbath, and O.A. Carretero Paracrine system in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats Hypertension 27 1996 7 13
27. T.F. Lüscher, and M. Barton Endothelins and endothelin receptor antagonists therapeutic consideration for a novel class of cardiovascular drugs Circulation 102 2000 2434 2440
28. T. Masaki Historical review: endothelin TRENDS Pharmacol. Sci. 25 2004 219 224
29. L. McMurdo, C. Thimermann, and J.R. Vane The effects of endothelin ETA receptor antagonist, FRI 139317, on the infarct size in a rabbit model of acute myocardial ischaemia-reperfusion Br. J. Pharmacol. 112 1994 75 80
30. G. Noll, and T.F. Lüscher The endothelium in acute coronary syndromes Eur. Heart J. 19 1998 C30 C38
31. M.K. Ozer, H. Parlakpinar, and A. Acet Reduction of ischemia-reperfusion induced myocardial infarct size in rats by caffeic acid phenethyl ester (CAPE) Clin. Biochem. 37 2004 702 705
32. R.M. Palmer, D.S. Asthon, and S. Moncada Vascular endothelial cells synthesize nitric oxide from l-arginine Nature 333 1988 664 666
33. H. Parlakpinar, M.K. Ozer, and A. Acet Effect of aminoguanidine on ischemia-reperfusion induced myocardial injury in rats Mol. Cell. Biochem. 277 2005 137 142
34. H. Parlakpinar, E. Sahna, A. Acet, B. Mizrak, and A. Polat Effect of caffeic acid phenethyl ester (CAPE) on myocardial ischemia-reperfusion induced apoptotic cell death Toxicology 207 2005 169 177
35. J. Pernow, and Q.-D. Wang Endothelin in myocardial ischemia and reperfusion Cardiovasc. Res. 33 1997 518 526
36. A receptor activation Am. J. Physiol. 264 1993 R222 R226
37. B antagonist Br. J. Pharmacol. 113 1994 869 876
38. E. Sahna, H. Parlakpinar, F. Ozturk, Y. Cigremis, and A. Acet The protective effects of physiological and pharmacological concentrations of melatonin on renal ischemia-reperfusion injury in rats Urol. Res. 31 2003 188 193
39. E. Sahna, H. Parlakpinar, Y. Turkoz, and A. Acet Protective effects of melatonin on myocardial ischemia-reperfusion induced infarct size and oxidative changes Physiol. Res. 54 2005 491 495
40. P.S. Tsao, N. Oki, D.J. Lefer, G. Johnson, and A.M. Lefer Time-course of endothelial dysfunction and myocardial injury during ischemia-reperfusion in the cat Circulation 82 1990 1402 1412
41. J.P. Valentin, D.G. Gardner, E. Wiedemann, and M.H. Humphreys Modulation of endothelin effects on blood pressure and hematocrit by atrial natriuretic peptide Hypertension 17 1991 864 869
42. N.P.E. Vermeulen, and G.S. Baldew The role of lipid peroxidation in the nephrotoxicity of cisplatin Biochem. Pharmacol. 44 1992 1193 1199
43. D.J. Webb, J.C. Monge, T.J. Rabelink, and M. Yanagisawa Endothelin: new discoveries and rapid progress in the clinic Meeting Report, Proceedings of the Fifth International Conference on Endothelin September 12-15, Kyoto, Japan 1997
44. A. Wennmalm, G. Benthin, and A.S. Petersson Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin Br. J. Pharmacol. 106 1992 507 518
45. S. Yamamoto, N. Matsumoto, M. Kanazawa, M. Fujita, M. Takaoka, C.E. Gariepy, M. Yanagisawa, and Y. Matsumura Different contributions of endothelin-A and endothelin-B receptors in postischemic cardiac dysfunction and nor epinephrine overflow in rat hearts Circulation 111 2005 302 309